Geographically, the developed regions such as North America and Europe together garner majority market share, about 70% of the global bio implants market (2013); however, going forward, it is estimated that the Asia Pacific regional market would lead with a sizable market share of about 20% (2020). Key factors attributable to such altered trend are increasing incidence of lifestyle diseases in the Asia-Pacific region coupled with increasing purchasing power among patients.
Bio-implants Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $115.8 billion by 2020, registering a CAGR of 10.3% during the period 2016 - 2022. Cardiovascular bio implants would garner sizable share among other segments, accounting for 30% of total market throughout the forecast period. Additionally, the orthopedic and dental bio implants are forecast to have a promising growth rate from 2014 to 2020.